Host-dependent editing of SARS-CoV-2 in COVID-19 patients.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 18 8 2021
medline: 10 9 2021
entrez: 17 8 2021
Statut: ppublish

Résumé

A common trait among RNA viruses is their high capability to acquire genetic variability due to viral and host mechanisms. Next-generation sequencing (NGS) analysis enables the deep study of the viral quasispecies in samples from infected individuals. In this study, the viral quasispecies complexity and single nucleotide polymorphisms of the SARS-CoV-2

Identifiants

pubmed: 34402744
doi: 10.1080/22221751.2021.1969868
pmc: PMC8425778
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1777-1789

Références

Emerg Microbes Infect. 2020 Dec;9(1):1900-1911
pubmed: 32752979
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Emerg Microbes Infect. 2020 Dec;9(1):837-842
pubmed: 32301390
Curr Top Microbiol Immunol. 2012;353:123-43
pubmed: 21732238
J Mol Biol. 1999 Aug 6;291(1):1-13
pubmed: 10438602
Nucleic Acids Res. 1995 Jul 25;23(14):2573-8
pubmed: 7544458
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
J Interferon Cytokine Res. 2014 Jun;34(6):437-46
pubmed: 24905200
Sci Rep. 2018 Oct 11;8(1):15177
pubmed: 30310104
Infect Drug Resist. 2018 Nov 08;11:2207-2210
pubmed: 30519058
PLoS One. 2018 Oct 3;13(10):e0204877
pubmed: 30281674
PLoS Pathog. 2013;9(12):e1003760
pubmed: 24348241
Biochemistry. 2000 Oct 24;39(42):12875-84
pubmed: 11041852
Algorithms Mol Biol. 2011 Nov 24;6:26
pubmed: 22115189
Virology. 2018 Oct;523:100-109
pubmed: 30107298
Nucleic Acids Res. 2020 Nov 18;48(20):11270-11283
pubmed: 33068416
PLoS Pathog. 2010 May 06;6(5):e1000896
pubmed: 20463816
Front Microbiol. 2020 Jul 22;11:1800
pubmed: 32793182
Cell. 1988 Oct 21;55(2):255-65
pubmed: 3167982
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W70-4
pubmed: 18424795
J Virol. 1999 Feb;73(2):1668-71
pubmed: 9882378
Bioinformatics. 2017 Nov 15;33(22):3645-3647
pubmed: 29036507
Clin Infect Dis. 2021 Jul 15;73(2):e437-e444
pubmed: 32649739
Nucleic Acids Res. 2009 Sep;37(17):5848-58
pubmed: 19651874
Curr Top Microbiol Immunol. 2012;353:163-95
pubmed: 21809195
Curr Opin Genet Dev. 1994 Dec;4(6):895-900
pubmed: 7888761
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15118-23
pubmed: 12399548
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
J Virol. 1997 Apr;71(4):2959-69
pubmed: 9060655
Virology. 2016 Jun;493:227-37
pubmed: 27060566
J Virol. 1997 Aug;71(8):6183-90
pubmed: 9223514
Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11787-91
pubmed: 7527543
Nature. 2021 Jul 8;:
pubmed: 34237774
Antiviral Res. 2020 Feb;174:104694
pubmed: 31857134
Nucleic Acids Res. 1981 Jan 10;9(1):133-48
pubmed: 6163133
Bioinformatics. 2014 Apr 15;30(8):1104-1111
pubmed: 24389655
Virology. 2015 Feb;476:364-371
pubmed: 25589239
J Clin Med. 2020 Oct 27;9(11):
pubmed: 33121037
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
Bioinformatics. 2009 Oct 1;25(19):2607-8
pubmed: 19654119
J Virol. 2008 Nov;82(21):10864-72
pubmed: 18753201
Rev Med Virol. 2011 Jan;21(1):42-53
pubmed: 21294215
RNA. 2020 Aug;26(8):937-959
pubmed: 32398273
PLoS Pathog. 2021 Jan 19;17(1):e1009226
pubmed: 33465137
Lancet. 2020 Aug 29;396(10251):603-611
pubmed: 32822564
Viruses. 2019 Aug 16;11(8):
pubmed: 31426357
Curr Issues Mol Biol. 2015;17:37-51
pubmed: 25502818
Genome Biol Evol. 2016 Oct 5;8(9):2952-2963
pubmed: 27614234
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
BMC Genet. 2009 Nov 26;10:75
pubmed: 19941656
Heart. 2020 Aug;106(15):1132-1141
pubmed: 32354800
J Virol. 2018 Jun 29;92(14):
pubmed: 29720522
Sci Adv. 2020 Jun 17;6(25):eabb5813
pubmed: 32596474

Auteurs

Josep Gregori (J)

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Roche Diagnostics SL, Barcelona, Spain.

Maria Francesca Cortese (MF)

Biochemistry and Microbiology Departments, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Maria Piñana (M)

Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Carolina Campos (C)

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

Damir Garcia-Cehic (D)

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

Cristina Andrés (C)

Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Josep Francesc Abril (JF)

Computational Genomics Lab, Genetics, Microbiology and Statistics Department, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain.

Maria Gema Codina (MG)

Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Ariadna Rando (A)

Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Juliana Esperalba (J)

Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Elena Sulleiro (E)

Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Joan Joseph (J)

Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Narcís Saubí (N)

Biochemistry and Microbiology Departments, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Sergi Colomer-Castell (S)

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Mari Carmen Martin (MC)

Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Carla Castillo (C)

Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Juan Ignacio Esteban (JI)

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Tomas Pumarola (T)

Microbiology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Universitat Autònoma de Barcelona, Bellaterra, Spain.

Francisco Rodriguez-Frias (F)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Biochemistry and Microbiology Departments, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Universitat Autònoma de Barcelona, Bellaterra, Spain.

Andrés Antón (A)

Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Universitat Autònoma de Barcelona, Bellaterra, Spain.

Josep Quer (J)

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH